The SGLN Biopharma Leaders Programme is designed to prepare Singaporeans for global leadership roles within the biopharmaceutical industry.

Developed in partnership with the Biopharmaceutical Manufacturers’ Advisory Council (BMAC), this co-created programme brings together senior biopharma leaders to collectively shape how Singapore develops and grows its next generation of biopharma leadership talent.

This is part of the SGLN Industry Interest Groups (SIIG) initiative launched by DPM and Minister for Trade & Industry Gan Kim Yong in September 2025.

The Singapore Leaders Network (SGLN) is managed by the Human Capital Leadership Institute (HCLI) and supported by the Singapore Economic Development Board (EDB). BMAC is an initiative by leading biopharmaceutical companies in the world to establish Singapore as the country of choice for global biopharma.

The SGLN Biopharma Programme was a meaningful and energising learning journey that challenged my perspectives, broadened my thinking, and helped me grow as a more effective leader.

Matthias Lim

Smart Manufacturing Director, GSK

A lot of exposure, networking & real-life solutioning for the biopharma industry. I made some great friends and learnt so much along the way. This has truly been a privilege!

Akshaya Deosthale

Senior Manager, Alcon

The SGLN Biopharma Programme is very enriching and eye-opening. I loved the sharings from senior leaders, which will help me reflect and enhance my own leadership skills.

Chang Xiang Yun

Head of CHO Upstream Operations, Roche

The SGLN Biopharma Leaders Programme was a highly enriching and eye-opening experience. It provided valuable exposure to global biopharma ecosystems, innovative technologies, and leadership practices.

Thiagu Dharuman

Production Manager, Kaneka

SGLN-BMAC Collaboration

The SGLN Biopharma Leaders Programme builds on the Biopharmaceutical Manufacturers’ Advisory Council’s (BMAC) pioneering groundwork and aligns with SGLN’s mission to prepare Singaporeans for global leadership roles in the biopharmaceutical industry. Through this partnership, SGLN and BMAC embarked on a co-creation journey — shaping a programme designed for the industry, by the industry.

Who is it for?

Singapore Citizens and PRs with 10 or more years of experience — high-potential leaders already trusted to deliver, and now ready to step into regional or global leadership roles within the next 5 years. These are our next-generation site heads, functional leads, and ecosystem connectors.

Three Components

Compulsory
01
Leadership Modules

Leadership development journey, comprising a local leadership module and a global expedition

Compulsory
02
Communities of Practice (CoPs)

Cross-company projects tackling industry challenges and shaping its future

Strongly Encouraged
03
Industry Networking & Learning Events

Platform to share insights, spark ideas, and explore the future of Biopharma

Learning Outcomes

Human Capital Leadership Institute

Thrive in a complex and ambiguous environment:
Build executive presence, influence, and sponsorship to lead with clarity and confidence across boundaries

Human Capital Leadership Institute

Create and leverage strategic networks, and communicate with clarity and authenticity for impact:
Strengthen collaboration across the biopharma ecosystem through strategic networks and peer exchange

Human Capital Leadership Institute

Demonstrate cultural flexibility for inclusive leadership:
Develop cross-market fluency and cultural agility through global immersions and experiences

Human Capital Leadership Institute

Gain new perspectives, mindsets, and inner motivation to courageously step outside the comfort zone:
Apply learning through outcome-driven projects that address real industry challenges

Learn global best practices across industries and develop ecosystem thinking:
Gain knowledge of leading practices in the world and develop the mindset to see connections and interdependencies that drive sustainable long-term impact

Ready to become an
SGLN Biopharma Leader Today?

For further enquiries, reach out to sgln.siig@hcli.org.